Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

IceCure Medical Ltd

ICCM
1,35
0,03 (2,27%)
07 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/2/202514:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/2/202514:30PRNUSIceCure Submits Filing for Regulatory Approval of its..
04/2/202514:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/2/202514:30PRNUSIceCure's ProSense® in the Spotlight at Society of..
27/1/202514:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/1/202514:30PRNUSIceCure Files for Regulatory Approval of ProSense®..
13/1/202514:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/1/202513:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/1/202513:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/1/202513:00PRNUSIceCure Medical CEO Issues Letter to Shareholders & Reports..
06/1/202514:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/1/202514:30PRNUSIceCure Medical Regains Full Nasdaq Compliance with Nasdaq..
03/1/202514:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202514:30PRNUSEuropean Patent Office Issues Intention to Grant Notice to..
30/12/202414:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/12/202414:30PRNUSData on IceCure's ProSense® Cryoablation for Low-Risk Breast..
05/12/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/12/202414:30PRNUSIceCure's ProSense® Cryoablation Safe and Effective in..
26/11/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/11/202414:30PRNUSIceCure Medical Reports 36% Sales Growth in the First Nine..
25/11/202414:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/11/202414:30PRNUSIceCure's Next-Generation Multiprobe Cryoablation Technology..
20/11/202414:30PRNUSIceCure Medical to Report Third Quarter 2024 Financial &..
19/11/202414:30PRNUSIceCure's ProSense® Chosen for Breast Cryoablation Study Led..
15/11/202403:38EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202416:05EDGAR2Form F-1/A - Registration statement for certain foreign..
08/11/202413:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202413:00PRNUSFDA Advisory Panel Votes in Favor of IceCure's ProSense®..
05/11/202422:41EDGAR2Form F-1/A - Registration statement for certain foreign..
29/10/202413:30PRNUSUpcoming FDA Advisory Panel for IceCure's ProSense®..
21/10/202414:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/10/202414:30PRNUSIceCure Receives Notice of Allowance from U.S. Patent and..
15/10/202422:22EDGAR2Form F-1 - Registration statement for certain foreign..
07/10/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/10/202414:15PRNUSIceCure's ProSense® Featured in 6 Global Studies on..
24/9/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/9/202414:15PRNUSIceCure's ICE3 5-Year Trial Results Published in the Peer..
16/9/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/9/202414:00PRNUSStudy Published in the British Journal of Radiology..
12/9/202414:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202414:00PRNUSIceCure Announces FDA Advisory Panel Meeting Date for..
04/9/202414:30PRNUSIceCure to Meet Institutional Investors at the H.C...
28/8/202414:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202414:30PRNUSUSPTO Grants Notice of Allowance for Additional Patent on..
20/8/202415:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/8/202414:30PRNUSIceCure Medical Reports 20% Growth in ProSense® System and..
16/8/202414:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/8/202414:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202414:30PRNUSIceCure's ProSense® Destroyed 100% of Breast Cancer Tumors..
13/8/202414:30PRNUSIceCure Medical to Report Second Quarter 2024 Financial &..
Apertura: 1,28 Min: 1,27 Max: 1,35
Chiusura: 1,32

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network